---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-114000"
form_type: "8-K"
ticker: "XRN"
cik: "0001533615"
company_name: "Chiron Real Estate Inc."
filed_at: "2022-11-02T23:59:59+00:00"
generated_at: "2026-06-22T13:42:58.317118+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Global Medical REIT Q3 net income $8.1M, AFFO $0.25/share; adds $150M term loan, 80% fixed-rate debt

## Summary
- Net income $8.1M ($0.12 diluted EPS) vs $3.7M ($0.06) prior year; revenue $35.4M, up 18.1% YoY
- FFO $16.2M ($0.23/sh/unit) flat; AFFO $17.1M ($0.25) up from $0.24 prior year
- Acquired $50.8M in Q3 (247k sf at 7.1% cap); YTD $148.9M; sold one asset for $17.9M, $6.8M gain
- Amended credit facility: $150M term loan added (Feb 2028), revolver extended to Aug 2026, switched to SOFR
- Entered $150M interest rate swaps fixing SOFR at 2.54%; 80% of debt now fixed at 3.75% wtd avg rate

## SEC filing metadata
- accession: 0001104659-22-114000
- form_type: 8-K
- ticker: XRN
- cik: 0001533615
- company_name: Chiron Real Estate Inc.
- filed_at: 2022-11-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533615/000110465922114000/0001104659-22-114000-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533615/000110465922114000/tm2229564d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-114000
- JSON: https://secwatch.observer/filing/0001104659-22-114000.json
- Plain text: https://secwatch.observer/filing/0001104659-22-114000.txt

## Key facts
- Earnings Releases
  Chiron Real Estate Inc. reported three months ended September 30, 2022 results: revenue $35.4 million, net income $8.1 million, EPS $0.12 per diluted share.
  - Period: three months ended September 30, 2022
  - Revenue: $35.4 million
  - Net income: $8.1 million
  - EPS: $0.12 per diluted share
  - Result: reported results
  source text: Net income attributable to common stockholders was $8.1 million, or $0.12 per diluted share, as compared to $3.7 million, or $0.06 per diluted share, in the comparable prior year period. · Funds from Operations (“FFO”) of $16.2 million, or $0.23 per share and unit, as compared to $15.8 million, or $0.23 per share and unit, in the comparable prior year period. · Adjusted Funds from Operations (“AFFO”) of $17.1 million, or $0.25 per share and unit, as compared to $16.4 million, or $0.24 per share and unit, in the comparable prior year period. · Increased total revenue 18.1% year-over-year to $35.4 million, primarily driven by the Company’s acquisition activity.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533615/000110465922114000/0001104659-22-114000-index.htm
- Earnings Releases
  Chiron Real Estate Inc. reported nine months ended September 30, 2022 results: revenue $101.0 million, net income $13.0 million, EPS $0.20 per diluted share.
  - Period: nine months ended September 30, 2022
  - Revenue: $101.0 million
  - Net income: $13.0 million
  - EPS: $0.20 per diluted share
  - Result: reported results
  source text: Net income attributable to common stockholders was $13.0 million, or $0.20 per diluted share, as compared to $8.0 million, or $0.13 per diluted share, in the comparable prior year period. · FFO of $48.6 million, or $0.70 per share and unit, as compared to $42.6 million, or $0.67 per share and unit, in the comparable prior year period. · AFFO of $51.5 million, or $0.74 per share and unit, as compared to $45.0 million, or $0.71 per share and unit, in the comparable prior year period. · Increased total revenue 18.0% year-over-year to $101.0 million, primarily driven by the Company’s acquisition activity.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533615/000110465922114000/0001104659-22-114000-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.